Summary of the KDIGO guideline on anemia and comment: reading between the (guide)line(s).

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Kidney International

• Publication date

  2012-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/ki.2012.270PMID 22854645
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS).

  2011cited by this paper
• A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.

  2009cited by this paper
• Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines.

  1999cited by this paper
• The ethics of practice guidelines.

  1996cited by this paper
• Achieving health gain through clinical guidelines II: Ensuring guidelines change medical practice.

  1994cited by this paper
• Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations.

  1993cited by this paper

• Effect of Intravenous Ferric Carboxymaltose Treatment on Serum Phosphorus Levels in Non-Dialysis Patients with Chronic Kidney Disease: A Retrospective Observational Study

  2026cites this paper
• Association of anemia with long-term renal prognosis in autosomal dominant polycystic kidney disease using time-series analysis.

  2026cites this paper
• Efficacy and safety of prolyl hydroxylase inhibitors for anemia in chronic kidney disease: a network meta-analysis

  2026cites this paper
• Anemia and iron deficiency in post-kidney transplantation: an unsolved challenge

  2025influential citation
• Ferric carboxymaltose use in pediatric kidney transplant recipients with iron deficiency

  2025cites this paper
• Time-updated patterns of hemoglobin and hematocrit and the risk of CKD progression

  2025cites this paper
• Individualized Diets in Patients with Kidney Disease and Kidney Transplants: A Narrative Review

  2025cites this paper
• Altered fecal microbial and metabolic profiles reveal potential mechanisms underlying anemia in patients with chronic renal failure

  2025cites this paper
• Response to Erythropoietin Stimulating Agents in Anemia of Chronic Kidney Disease Patients

  2025cites this paper
• Safety and Efficacy of Vadadustat for the Treatment of CKD-Related Anemia within and outside the United States.

  2025cites this paper
• A deterministic large language model (LLM) framework for safe, protocol-adherent clinical decision support: application in hemodialysis anemia management (AnemiaCare HDs)

  2025cites this paper
• Iron in Chronic Kidney Disease and End-Stage Kidney Disease-Current Trends and Future Direction.

  2025cites this paper
• Attribute based cross classification analyses from the BRIGHTEN study reveal that therapeutic responsiveness to erythropoiesis stimulating agents predicts cardiorenal prognosis in renal anemia

  2025cites this paper
• Effects of rhEPO-Fc on chronic renal anemia in Chinese patients undergoing maintenance hemodialysis: a multicenter, randomized, open-label, and phase 3 study

  2025cites this paper
• Left heart function and strain for predicting change in hemoglobin levels in pediatric kidney transplantation recipients

  2025cites this paper
• Anemia of Chronic Kidney Disease in India: Consensus Guidelines of Indian Society of Nephrology

  2025cites this paper
• Prescript peritoneal dialysis: Patterns of iron prescribing in peritoneal dialysis.

  2025cites this paper
• A Systematic Review Investigates the Safety and Efficacy of Intravenous Iron Dosing in Peritoneal Dialysis.

  2025cites this paper
• Purpuric rash after starting hemodialysis—not the immediate suspect: a case report and literature review

  2025cites this paper
• Cinacalcet Improves Erythropoietin Resistance in Patients with Secondary Hyperparathyroidism Receiving Dialysis Treatment.

  2025cites this paper
• Renal Foot in Diabetes: Implications for Wound Healing and Solutions.

  2025cites this paper
• Determinants of anemia in patients with primary glomerulonephritis: a biopsy-based analysis.

  2025cites this paper
• Haemodynamic consequences of acute pulmonary embolism predict risk of CTPA‐related acute kidney injury

  2025cites this paper
• Correlation Between Hepatic Iron and Fat in Hemodialysis Patients: A Quantitative MRI Analysis

  2025cites this paper
• Optimizing hepatitis B vaccination in chronic kidney disease: a comprehensive scoping review of strategies across CKD stages, dialysis, and transplant populations

  2025influential citation
• Prognostic nutritional index as an independent risk factor for disease progression in patients with IgA nephropathy

  2025cites this paper
• Adaptability of clinical pharmacist led interventions in the management of anemia of chronic renal disease: optimizing care

  2024influential citation
• Iron Indices Mediate but Not Modify Association of Parathyroid Hormone with Erythropoietin Resistance in Hemodialysis Patients

  2024cites this paper
• Roxadustat has risks of reversible central hypothyroidism in patients undergoing hemodialysis: a single-center retrospective cohort study

  2024cites this paper
• Usage of the Anemia Control Model Is Associated with Reduced Hospitalization Risk in Hemodialysis

  2024cites this paper
• Ziltivekimab for anemia and atherosclerosis in chronic kidney disease: a new hope?

  2024cites this paper
• Risk factors and current state of therapy for anemia after kidney transplantation

  2024cites this paper
• Low-Protein Diets Could Be Effective and Safe in Elderly Patients with Advanced Diabetic Kidney Disease

  2024cites this paper
• A whole-body mechanistic physiologically-based pharmacokinetic modeling of intravenous iron

  2024cites this paper
• MicroR-380-3p Reduces Sepsis-Induced Acute Kidney Injury via Regulating RAB1P to Restrain NF-κB Pathway.

  2024cites this paper
• Anemia of Chronic Kidney Disease—A Narrative Review of Its Pathophysiology, Diagnosis, and Management

  2024cites this paper
• Impact of transferrin saturation on cardiovascular events in non-dialysis-dependent chronic kidney disease patients treated with darbepoetin alfa

  2024cites this paper
• Sarcopenia is associated with increased major adverse cardiovascular event incidence in maintenance hemodialysis patients: a prospective cohort study and mediation analysis

  2024cites this paper
• The mmu_circ_003062, hsa_circ_0075663/miR-490-3p/CACNA1H axis mediates apoptosis in renal tubular cells in association with endoplasmic reticulum stress following ischemic acute kidney injury.

  2024cites this paper
• Considerations regarding anesthesia for renal transplantation

  2024cites this paper
• Case report: Roxadustat overdose in an anemia patient of chronic kidney disease: insight beyond insignificant consequence

  2024cites this paper
• CIRCVMA21-RELATED PATHWAY ALLEVIATES LIPOPOLYSACCHARIDE-INDUCED HK-2 CELL INJURY

  2024cites this paper
• Cardiovascular and non‐renal complications of chronic kidney disease: Managing risk

  2024cites this paper
• Erythropoietin Resistance Index in Hemodialysis Patients: A Single Moroccan Center Experience

  2024cites this paper
• Role of selenium in the pathophysiology of cardiorenal anaemia syndrome

  2024cites this paper
• Prevalence, risk factors, and treatment of anemia in hospitalized older patients across geriatric and nephrological settings in Italy

  2024influential citation
• Safety of High-Dose Intravenous Iron in Hemodialysis Patients: Results from the National Health Insurance Service (2019–2020) in South Korea

  2024cites this paper
• Iron deficiency, anemia, and patient-reported outcomes in kidney transplant recipients.

  2024cites this paper
• Unresolved aspects in the management of renal anemia, a Delphi consensus of the Anemia Group of the S.E.N.

  2023cites this paper
• Iron Deficiency Might Impair the Recovery of Left Ventricular Function after Surgical Revascularization in Diabetic Patients: A Retrospective Study

  2023cites this paper
• The Resolution of a Cerebrovascular Accident With Phlebotomy in a Hemodialysis Patient With Sickle Cell Disease

  2023cites this paper
• Effectiveness of iron-based phosphate binders in reduction of hyperphosphataemia in chronic kidney disease patients

  2023cites this paper
• Association of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors with Cardiovascular Events and Death in Dialysis Patients: A Systematic Review and Meta-Analysis

  2023cites this paper
• Effects of Proton Pump Inhibitors on Patient Survival in Patients Undergoing Maintenance Hemodialysis

  2023cites this paper
• Management of Anemia in Elderly Patient with Chronic Kidney Disease

  2023cites this paper
• Predictive role of cardiac valvular calcification in all-cause mortality of Chinese initial haemodialysis patients: a follow-up study of 4 years

  2023cites this paper
• Effects of hypoxia-inducible factor-prolyl hydroxylase inhibitors vs. erythropoiesis-stimulating agents on iron metabolism in non-dialysis-dependent anemic patients with CKD: A network meta-analysis

  2023cites this paper
• A New Understanding of Potassium's Influence Upon Human Health and Renal Physiology.

  2023cites this paper
• Association between serum total cholesterol and chronic kidney disease progression in children: results from the KNOW-PedCKD

  2023cites this paper
• Serum iron levels in tuberculosis patients and household contacts and its association with natural resistance‐associated macrophage protein 1 polymorphism and expression

  2023cites this paper
• Regular laboratory testing and patient survival among patients undergoing maintenance hemodialysis: a Korean nationwide cohort study

  2023cites this paper
• How to diagnose iron deficiency in chronic disease: A review of current methods and potential marker for the outcome

  2023cites this paper
• Iron Supplements Concomitant within Hypoxia-Inducible Factor Prolyl Hydroxylase Domain Inhibitors in the Treatment of Chronic Kidney Disease Anemia

  2023cites this paper
• A retrospective view of the relationship of soluble Fas with anemia and outcomes in chronic kidney disease

  2023cites this paper
• Inflammation alters iron distribution in bone and spleen in mice.

  2023cites this paper
• Diabetic kidney disease in type 2 diabetes: a consensus statement from the Swiss Societies of Diabetes and Nephrology.

  2023cites this paper
• Impact of renal complications on outcome in adult patients with acute fulminant myocarditis receiving venoarterial extracorporeal membrane oxygenation: an analysis of nationwide CSECLS database in China

  2023influential citation
• ESKD: Peritoneal Dialysis

  2023cites this paper
• Fibroblast growth-factor 23 and vitamin D are associated with iron deficiency and anemia in children with chronic kidney disease

  2023cites this paper
• Serum ferritin/C-reactive protein ratio is a simple and effective biomarker for diagnosing iron deficiency in the context of systemic inflammation.

  2023cites this paper
• Sickle Cell Disease and CKD: An Update

  2023influential citation
• Nutrition and anemia in chronic kidney disease

  2022cites this paper
• HEMODİALİZ HASTALARINDA TEDAVİ UYUMU VE AKILLI İLAÇ KULLANIMININ DEĞERLENDİRİLMESİ VE DİYALİZ YETERLİLİĞİNİ ÖNGÖRÜCÜ FAKTÖRLER

  2022cites this paper
• Adherence to multidisciplinary care in a prospective chronic kidney disease cohort is associated with better outcomes

  2022cites this paper
• Cardiovascular Disease Assessment Prior to Kidney Transplantation

  2022cites this paper
• The novel biomarker circ_0020339 drives septic acute kidney injury by targeting miR-17-5p/IPMK axis

  2022cites this paper
• Executive summary of the Korean Society of Nephrology 2021 clinical practice guideline for optimal hemodialysis treatment

  2022influential citation
• The relationships among gut microbiota, hypoxia‐inducible factor and anaemia with chronic kidney disease

  2022cites this paper
• Safety of Intravenous Iron in CKD Stage 3-5 Patients Not on Dialysis: A Retrospective Cohort Study

  2022cites this paper
• Frequency of Iron Deficiency Anemia in Pre-dialysis Chronic Kidney Disease Patients

  2022cites this paper
• Anaesthetic Approach to Enhanced Recovery after Surgery for Kidney Transplantation: A Narrative Review

  2022cites this paper
• Selenium Associates With Response to Erythropoiesis-Stimulating Agents in Hemodialysis Patients

  2022influential citation
• Approach to refractory

  2022cites this paper
• Efficacy and Safety of Daprodustat Vs rhEPO for Anemia in Patients With Chronic Kidney Disease: A Meta-Analysis and Trial Sequential Analysis

  2022cites this paper
• Anemia of chronic kidney disease: Will new agents deliver on their promise?

  2022influential citation
• Role of Erythropoiesis-Stimulating Agents in Cardiovascular Protection in CKD Patients: Reappraisal of Their Impact and Mechanisms

  2022cites this paper
• Pleotropic effects of hypoxia-inducible factor-prolyl hydroxylase domain inhibitors: are they clinically relevant?

  2022cites this paper
• Effects of ferric citrate and intravenous iron sucrose on markers of mineral, bone, and iron homeostasis in a rat model of CKD-MBD.

  2022cites this paper
• Prescription rate of erythropoietin-stimulating agents is low for patients with renal impairment under non-nephrology care in a tertiary-level academic medical center in Japan

  2022cites this paper
• HIF-PH-Inhibitoren in der Therapie der renalen Anämie

  2022cites this paper
• Bone Marrow Findings in Renal Patients: A Single Renal Specialist Center Experience

  2021cites this paper
• Long Non-Coding RNA CASC2 Overexpression Ameliorates Sepsis-Associated Acute Kidney Injury by Regulating MiR-545-3p/PPARA axis.

  2021cites this paper
• Status of Anemia According to Underlying Renal Disease in Chronic Kidney Disease: The Fukushima CKD Cohort

  2021cites this paper
• Role of Peritoneal Dialysis in Acute Kidney Injury

  2021cites this paper
• Concomitant Lung and Kidney Disorders in Critically Ill Patients: Core Curriculum 2022.

  2021cites this paper
• Dialysis Center Productivity Accelerated after 2011 Payment Reform without Compromising Quality of Care

  2021cites this paper
• The gut microbiome in microscopic polyangiitis with kidney involvement: common and unique alterations, clinical association and values for disease diagnosis and outcome prediction

  2021cites this paper
• NT-proBNP as a Potential Marker of Cardiovascular Damage in Children with Chronic Kidney Disease

  2021cites this paper
• Suppression of thyrotropin secretion during roxadustat treatment for renal anemia in a patient undergoing hemodialysis

  2021cites this paper
• Erythropoietin in Lupus: Unanticipated Immune Modulating Effects of a Kidney Hormone

  2021cites this paper